IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $809,041 | +8.0% | 17,836 | -2.4% | 0.01% | +10.0% |
| Q2 2023 | $749,454 | +17.0% | 18,266 | +1.9% | 0.01% | +11.1% |
| Q1 2023 | $640,711 | -4.2% | 17,927 | +1.2% | 0.01% | -18.2% |
| Q4 2022 | $668,907 | -2.6% | 17,710 | +14.0% | 0.01% | -15.4% |
| Q3 2022 | $687,000 | +20.3% | 15,540 | +0.8% | 0.01% | +18.2% |
| Q2 2022 | $571,000 | +3.4% | 15,418 | +3.5% | 0.01% | +22.2% |
| Q1 2022 | $552,000 | +21.9% | 14,898 | +0.1% | 0.01% | +28.6% |
| Q4 2021 | $453,000 | -7.4% | 14,890 | +2.2% | 0.01% | -22.2% |
| Q3 2021 | $489,000 | -19.4% | 14,572 | -4.3% | 0.01% | -18.2% |
| Q2 2021 | $607,000 | +98.4% | 15,226 | +123.8% | 0.01% | +83.3% |
| Q1 2021 | $306,000 | -20.1% | 6,803 | +0.3% | 0.01% | -25.0% |
| Q4 2020 | $383,000 | +22.8% | 6,780 | +3.2% | 0.01% | 0.0% |
| Q3 2020 | $312,000 | -22.0% | 6,571 | -3.2% | 0.01% | -20.0% |
| Q2 2020 | $400,000 | – | 6,786 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |